tiprankstipranks
Cipher Pharmaceuticals (DE:PHE)
FRANKFURT:PHE

Cipher Pharmaceuticals (PHE) Ownership - Who Owns Cipher Pharmaceuticals?

1 Followers

Cipher Pharmaceuticals (PHE) Ownership Overview

0.00%0.00%0.77%99.23%
0.77% Other Institutional Investors
99.23% Public Companies and
Individual Investors
The ownership structure of Cipher Pharmaceuticals (DE:PHE) stock is a mix of institutional, retail and individual investors. Approximately 0.77% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.23% is owned by Public Companies and Individual Investors.
The ownership structure of Cipher Pharmaceuticals (DE:PHE) stock is a mix of institutional, retail and individual investors. Approximately 0.77% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,244Insider25,252
50,003Insider297,518
32,516Insider193,470
5,550Insider33,023
1,461Insider8,693
7,886Insider46,922
5,849Insider34,802
1,540Insider9,163
2,396Insider14,256
400Insider2,380

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,369Institution14,967
224,700Institution1,419,655

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Cipher Pharmaceuticals (DE:PHE)?
According to the latest TipRanks data, approximately 0.77% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.23% is held by retail investors.
    What percentage of Cipher Pharmaceuticals (DE:PHE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.77% of Cipher Pharmaceuticals (DE:PHE) stock is held by institutional investors.
      What percentage of Cipher Pharmaceuticals (DE:PHE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 99.23% of Cipher Pharmaceuticals (DE:PHE) stock is held by retail investors.
        Who owns the most shares of Cipher Pharmaceuticals (DE:PHE)?
        Peter John Wieler owns the most shares of Cipher Pharmaceuticals (DE:PHE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis